Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)
CUSIP: 22978P106
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 43,411,663
- Total 13F shares
- 18,058,960
- Share change
- +723,240
- Total reported value
- $12,982,249
- Price per share
- $0.72
- Number of holders
- 52
- Value change
- +$519,709
- Number of buys
- 14
- Number of sells
- 16
Quarterly Holders Quick Answers
What is CUSIP 22978P106?
CUSIP 22978P106 identifies CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 22978P106:
Top shareholders of CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bleichroeder LP |
13D/G
13F
|
Company |
10%
|
6,127,662
|
$5,269,789 | $0 | 19 Mar 2025 | |
| Michael J. Fox |
3/4/5
|
Director |
—
mixed-class rows
|
1,148,800
mixed-class rows
|
$3,036,000 | — | 05 Jun 2024 | |
| GC Wealth Management RIA, LLC |
13F
|
Company |
7.7%
|
3,331,644
|
$2,273,181 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.3%
|
3,187,346
|
$2,173,770 | — | 30 Jun 2025 | |
| Cameron Gray |
3/4/5
|
Director |
—
class O/S missing
|
687,049
|
$1,896,255 | — | 14 Jun 2022 | |
| Mark E. Strome |
13D/G
|
— |
5%
|
2,166,242
|
$1,862,968 | $0 | 14 Nov 2022 | |
| Slate Path Capital LP |
13D/G
|
— |
1.4%
|
918,836
|
$790,199 | $0 | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
692,173
|
$472,350 | — | 30 Jun 2025 | |
| Anish Suri |
3/4/5
|
PRESIDENT AND CSO |
—
mixed-class rows
|
285,638
mixed-class rows
|
$374,361 | — | 05 Jun 2024 | |
| Robertson Stephens Wealth Management, LLC |
13F
|
Company |
1.1%
|
478,500
|
$326,481 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1%
|
449,162
|
$306,463 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.75%
|
324,584
|
$221,366 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.67%
|
292,583
|
$199,542 | — | 30 Jun 2025 | |
| ADVISORY RESEARCH INC |
13F
|
Company |
0.59%
|
257,225
|
$175,505 | — | 30 Jun 2025 | |
| Daniel R. Passeri |
3/4/5
|
CHIEF EXECUTIVE OFFICER, Director |
—
mixed-class rows
|
614,578
mixed-class rows
|
$169,515 | — | 21 Mar 2025 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.45%
|
196,556
|
$134,110 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.44%
|
189,753
|
$129,468 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.36%
|
154,243
|
$105,240 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.31%
|
133,464
|
$91,063 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.31%
|
132,573
|
$90,455 | — | 30 Jun 2025 | |
| ANGELES WEALTH MANAGEMENT, LLC |
13F
|
Company |
0.28%
|
120,000
|
$81,876 | — | 30 Jun 2025 | |
| Chicago Partners Investment Group LLC |
13F
|
Company |
0.2%
|
88,302
|
$78,589 | — | 30 Jun 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.19%
|
83,000
|
$56,631 | — | 30 Jun 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.14%
|
59,390
|
$40,522 | — | 30 Jun 2025 | |
| Sigma Planning Corp |
13F
|
Company |
0.13%
|
55,500
|
$37,868 | — | 30 Jun 2025 | |
| Texas Capital Bank Wealth Management Services Inc |
13F
|
Company |
0.08%
|
33,102
|
$22,585 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
29,452
|
$20,096 | — | 30 Jun 2025 | |
| Navalign, LLC |
13F
|
Company |
0.06%
|
25,000
|
$17,058 | — | 30 Jun 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.05%
|
22,493
|
$15,347 | — | 30 Jun 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.05%
|
20,667
|
$14,000 | — | 30 Jun 2025 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.05%
|
20,000
|
$14,000 | — | 30 Jun 2025 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0.05%
|
20,000
|
$13,646 | — | 30 Jun 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.05%
|
19,577
|
$13,357 | — | 30 Jun 2025 | |
| PREVAIL INNOVATIVE WEALTH ADVISORS, LLC |
13F
|
Company |
0.04%
|
18,987
|
$12,955 | — | 30 Jun 2025 | |
| Michael Salzhauer |
13F
|
Individual |
0.04%
|
16,000
|
$10,917 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
14,376
|
$9,809 | — | 30 Jun 2025 | |
| SeaCrest Wealth Management, LLC |
13F
|
Company |
0.03%
|
13,000
|
$8,870 | — | 30 Jun 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.03%
|
11,812
|
$8,000 | — | 30 Jun 2025 | |
| Beacon Pointe Advisors, LLC |
13F
|
Company |
0.02%
|
10,000
|
$6,823 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
7,030
|
$4,797 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
6,029
|
$4,114 | — | 30 Jun 2025 | |
| Gleason Group, Inc. |
13F
|
Company |
0.01%
|
6,000
|
$4,094 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.01%
|
3,350
|
$2,286 | — | 30 Jun 2025 | |
| Newbridge Financial Services Group, Inc. |
13F
|
Company |
0.01%
|
3,000
|
$2,047 | — | 30 Jun 2025 | |
| Golden State Wealth Management, LLC |
13F
|
Company |
0%
|
2,000
|
$1,365 | — | 30 Jun 2025 | |
| Tidemark, LLC |
13F
|
Company |
0%
|
1,500
|
$1,023 | — | 30 Jun 2025 | |
| Physician Wealth Advisors, Inc. |
13F
|
Company |
0%
|
1,006
|
$687 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
715
|
$488 | — | 30 Jun 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
680
|
$463 | — | 30 Jun 2025 | |
| Sunbelt Securities, Inc. |
13F
|
Company |
0%
|
237
|
$258 | — | 30 Jun 2025 |
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q3 2025
As of 30 Sep 2025,
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,058,960 shares.
The largest 10 holders included
Bleichroeder LP, GC Wealth Management RIA, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BOOTHBAY FUND MANAGEMENT, LLC, Robertson Stephens Wealth Management, LLC, BlackRock, Inc., BANK OF AMERICA CORP /DE/, ADVISORY RESEARCH INC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
52
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
46
Q3 2025 holders
52
Holder diff
6
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.